EPN
EPSILON FPO [EPN]
Healthcare · ASX Small Cap
$0.0270 +3.8%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +8First seen: 2026-02-25
Score Breakdown
Technical71
Catalyst54
Sentiment50
Fundamental41
Momentum64
Risk Gate30
Active Signals
Bullish Signals
- RSI approaching oversold
- Stochastic oversold
- Volatility contracting (breakout setup)
- Above 200-day MA (long-term uptrend)
- Critical cash runway (0.8 quarters)
- Low P/S ratio (1.6x)
- Moderate revenue growth (+19%)
- Near 52-week low (12% of range)
- Micro-cap ($5-20M) - high risk
- New substantial holder(s) (1)
- Positive 12-1 momentum (+29%)
- Altman Z-Score in distress zone (-0.06 < 1.81)
- Low-priced stock risk ($0.026)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: PHASE1 (est. 2010-12)
Risk Signals
- Price below MAs (downtrend)
- Piotroski F-Score weak (2/9)
- Deeply negative margins (-100%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Preliminary Final Report
NONE Establishment of New Epsilon Biotech Subsidiary
NONE Application for quotation of securities - EPN
HIGH Becoming a substantial holder
Recent ASX Announcements
| 2026-02-27 | Preliminary Final Report PRICE SENSITIVE |
| 2026-02-17 | Establishment of New Epsilon Biotech Subsidiary |
| 2026-02-11 | Application for quotation of securities - EPN |
| 2026-02-06 | Becoming a substantial holder |
| 2026-02-05 | Application for quotation of securities - EPN |
Key Metrics
$10.1M
Market Cap
174K
Avg Volume
1.1x
Vol Ratio
$0.02 — $0.04
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-494.0%
ROE
-99.9%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 62% |
| L | Leader vs Laggard | pass | RS: 3 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #11 of 119 · Sector avg: 51
View all Healthcare signals →